Opioid Induced Constipation

Lifetree Clinical Research is currently testing investigational treatments that are being developed for opioid constipation and other manifestations of bowel dysfunction in patients receiving prescription opioids for pain.

The goal of this investigational treatment for opioid constipation is to reduce constipation while preserving the effects of opioid therapy. Constipation is the hallmark of this syndrome. However, this investigational treatment may also help opioid induced bowel dysfunction, a condition that may also include other symptoms like bloating, abdominal cramping and gastroesophageal reflux.

Statistics

In the United States, patients with a variety of underlying conditions receive a total of approximately 1.2 billion days of opioid therapy for pain that is treated for at least 15 days. A few examples of opioid medications are lortab, percocet and oxycontin another word for opioids is narcotics. Fifteen to 90% of patients receiving opioids develop constipation. Current treatment for opioid induced constipation, which includes laxatives, stool softeners and if necessary, reflex evacuation via enema – is distinctly sub-optimal with up to 46% of patients not achieving the desired treatment outcome.

Join our Research Study

If you are between the ages of 18 and 70, suffering from constipation from opioids, and can stay multiple days in our research facility, then call for a confidential screening at (801) 269-8200. You will receive financial compensation for your participation, and health insurance is not required to participate.

Lifetree Clinical Research® is currently conducting a clinical trial. To find out more about this study click here.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player






"Our clients receive unparalleled individualized attention from expert researchers, physicians, investigators and thought leaders."

Alice A. Jackson RN
Founder, President
Lifetree Clinical Research